Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Mario Enrico Canonico to Spironolactone

This is a "connection" page, showing publications Mario Enrico Canonico has written about Spironolactone.

 
Connection Strength
  
 
 
1.005
  
  1. Basile C, Monzo L, Farmakis D, Keramida K, Liori S, Kapelios CJ, Sverdlov AL, Grupper A, Ambrosy AP, Canonico ME. Trials and tribulations of spironolactone in heart failure with preserved ejection fraction: Insights from the SPIRIT-HF trial. Heart Fail Rev. 2026 Aug 31; 31(1).
    View in: PubMed
    Score: 0.949
  2. Harrington JL, Canonico ME, El Rafei A, Solomon SD, Teerlink JR, Vaduganathan M, Zieroth SR, Bonaca MP, Sauer AJ. Nonsteroidal and Steroidal Mineralocorticoid Antagonists: Rationale, Evidence, and Unanswered Questions. JACC Heart Fail. 2025 Oct; 13(10):102637.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)